These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36282074)

  • 41. Vernakalant and electrical cardioversion for AF - Safe and effective.
    Simon A; Niederdoeckl J; Janata K; Spiel AO; Schuetz N; Schnaubelt S; Herkner H; Cacioppo F; Laggner AN; Domanovits H
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100398. PubMed ID: 31338415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment.
    Cristoni L; Tampieri A; Mucci F; Iannone P; Venturi A; Cavazza M; Lenzi T
    Emerg Med J; 2011 Nov; 28(11):932-7. PubMed ID: 20947916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals.
    Stiell IG; Clement CM; Rowe BH; Brison RJ; Wyse DG; Birnie D; Dorian P; Lang E; Perry JJ; Borgundvaag B; Eagles D; Redfearn D; Brinkhurst J; Wells GA
    Ann Emerg Med; 2017 May; 69(5):562-571.e2. PubMed ID: 28110987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.
    Stiell IG; Sivilotti MLA; Taljaard M; Birnie D; Vadeboncoeur A; Hohl CM; McRae AD; Rowe BH; Brison RJ; Thiruganasambandamoorthy V; Macle L; Borgundvaag B; Morris J; Mercier E; Clement CM; Brinkhurst J; Sheehan C; Brown E; Nemnom MJ; Wells GA; Perry JJ
    Lancet; 2020 Feb; 395(10221):339-349. PubMed ID: 32007169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrical cardioversion for atrial fibrillation in the emergency department: A large single-center experience.
    Fried AM; Strout TD; Perron AD
    Am J Emerg Med; 2021 Apr; 42():115-120. PubMed ID: 32093961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial.
    Camm AJ; Toft E; Torp-Pedersen C; Vijayaraman P; Juul-Moller S; Ip J; Beatch GN; Dickinson G; Wyse DG;
    Europace; 2012 Jun; 14(6):804-9. PubMed ID: 22291438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis.
    Guerra F; Matassini MV; Scappini L; Urbinati A; Capucci A
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1067-75. PubMed ID: 25096598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation.
    Decker WW; Smars PA; Vaidyanathan L; Goyal DG; Boie ET; Stead LG; Packer DL; Meloy TD; Boggust AJ; Haro LH; Laudon DA; Lobl JK; Sadosty AT; Schears RM; Schiebel NE; Hodge DO; Shen WK
    Ann Emerg Med; 2008 Oct; 52(4):322-8. PubMed ID: 18339449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.
    Roy D; Pratt CM; Torp-Pedersen C; Wyse DG; Toft E; Juul-Moller S; Nielsen T; Rasmussen SL; Stiell IG; Coutu B; Ip JH; Pritchett EL; Camm AJ;
    Circulation; 2008 Mar; 117(12):1518-25. PubMed ID: 18332267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vernakalant for the conversion of atrial fibrillation: the new kid on the block?
    Conde D; Baranchuk A
    Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):299-302. PubMed ID: 24738652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vernakalant for the conversion of atrial fibrillation of recent onset].
    Seoane L; Baranchuk A; Conde D
    Medicina (B Aires); 2015; 75(4):239-44. PubMed ID: 26339882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D; Costabel JP; Aragon M; Lambardi F; Klein A; Corrales Barbosa A; Trivi M; Giniger A
    Cardiovasc Ther; 2013 Dec; 31(6):377-80. PubMed ID: 23683253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Multicenter Randomized Trial to Evaluate a Chemical-first or Electrical-first Cardioversion Strategy for Patients With Uncomplicated Acute Atrial Fibrillation.
    Scheuermeyer FX; Andolfatto G; Christenson J; Villa-Roel C; Rowe B
    Acad Emerg Med; 2019 Sep; 26(9):969-981. PubMed ID: 31423687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spotlight on intravenous vernakalant in recent-onset atrial fibrillation.
    Duggan ST; Scott LJ
    Drugs Aging; 2011 Jun; 28(6):501-4. PubMed ID: 21639409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation.
    Pluymaekers NAHA; Dudink EAMP; Luermans JGLM; Meeder JG; Lenderink T; Widdershoven J; Bucx JJJ; Rienstra M; Kamp O; Van Opstal JM; Alings M; Oomen A; Kirchhof CJ; Van Dijk VF; Ramanna H; Liem A; Dekker LR; Essers BAB; Tijssen JGP; Van Gelder IC; Crijns HJGM;
    N Engl J Med; 2019 Apr; 380(16):1499-1508. PubMed ID: 30883054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is emergency department cardioversion of recent-onset atrial fibrillation safe and effective?
    Cohn BG; Keim SM; Yealy DM
    J Emerg Med; 2013 Jul; 45(1):117-27. PubMed ID: 23643237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis.
    deSouza IS; Tadrous M; Sexton T; Benabbas R; Carmelli G; Sinert R
    Europace; 2020 Jun; 22(6):854-869. PubMed ID: 32176779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutter.
    Stiell IG; Sivilotti MLA; Taljaard M; Birnie D; Vadeboncoeur A; Hohl CM; McRae AD; Morris J; Mercier E; Macle L; Brison RJ; Thiruganasambandamoorthy V; Rowe BH; Borgundvaag B; Clement CM; Brinkhurst J; Brown E; Nemnom MJ; Wells GA; Perry JJ
    CJEM; 2021 May; 23(3):314-324. PubMed ID: 33959925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland.
    Kiliszek M; Opolski G; Włodarczyk P; Dąbrowski R; Ponikowski P
    Cardiol J; 2014; 21(5):484-91. PubMed ID: 24526513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of transesophageal echocardiogram-guided electrical cardioversion in patients with atrial fibrillation greater than 48 hours treated in the emergency department versus the cardiology ward: A retrospective comparison study.
    Zaro B; Alpert EA; Kaufman N; Rosenmann D
    Int J Clin Pract; 2021 Sep; 75(9):e14480. PubMed ID: 34107147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.